Literature DB >> 3555583

Captopril and hydrochlorothiazide: rationale for their combination.

E Ambrosioni, C Borghi, F V Costa.   

Abstract

The results of controlled clinical studies have shown that about 80% of hypertensive patients have a satisfactory blood pressure reduction when treated with a combination of captopril and thiazide diuretics. The high response rate to this treatment can be explained on the basis of the mechanism of action of these drugs. In the long term, diuretics act by reducing peripheral vascular resistance. The mechanism by which they reduce peripheral vascular resistance is the subject of debate, but could be explained on the basis of cellular ionic changes. From our studies, it was observed that thiazides cause a reduction in intracellular Na+ (Nai) and in intra- and extracellular K+ (Ki, Ke). Since in many patients Ke losses are greater than Ki losses, the Ki/Ke ratio (which is directly related to membrane potential and thus to vascular tone) increases. Captopril also reduces Nai, but its effects on Ke and Ki are quite different from those of thiazides. Captopril in fact causes an increase in Ki inducing a net increase in Ki/Ke. This increase can also be observed when captopril is given in combination with thiazides. Therefore the combination of captopril and thiazides has an additive effect on Nai, and increases Ki/Ke in the vast majority of patients. The decrease in Nai probably acts by reducing membrane sensitivity to catecholamines and angiotensin, whereas the increase in Ki/Ke acts by hyperpolarizing vascular smooth muscle membrane. The combination of captopril an thiazides also has favourable metabolic effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555583      PMCID: PMC1386045          DOI: 10.1111/j.1365-2125.1987.tb03121.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Disparate patterns of aldosterone response during diuretic treatment of hypertension.

Authors:  M A Weber; J I Drayer; A Rev; J H Laragh
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

2.  Influence of sodium and potassium content on arterial responsiveness.

Authors:  T F Burks; C T Spalding; V D Jones
Journal:  Circ Res       Date:  1971-11       Impact factor: 17.367

3.  Water content of arteriolar wall in renovascular hypertension.

Authors:  L Tobian; R Olson; G Chesley
Journal:  Am J Physiol       Date:  1969-01

4.  Angiotensin-converting enzyme inhibitors in the treatment of hypertension.

Authors:  C I Johnston; L Arnolda; M Hiwatari
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

5.  Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients.

Authors:  G Leonetti; L Terzoli; C Sala; C Bianchini; L Sernesi; A Zanchetti
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

6.  Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients.

Authors:  M H Weinberger
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  Captopril and hydrochlorothiazide in the fixed combination multicenter trial.

Authors:  R M Lederle
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

8.  Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.

Authors:  F V Costa; C Borghi; E Ambrosioni
Journal:  Clin Ther       Date:  1984       Impact factor: 3.393

Review 9.  Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis.

Authors:  M P Blaustein
Journal:  Am J Physiol       Date:  1977-05

10.  Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders.

Authors:  P van Brummelen; A J Man in 't Veld; M A Schalekamp
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

View more
  10 in total

Review 1.  Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy?

Authors:  D A Sica
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 2.  Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.

Authors:  Domenic A Sica
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Hydrochlorothiazide versus calcium channel blockers: what is the best add-on to a renin-angiotensin system blocker for treating hypertension in patients with renal disease?

Authors:  Edgar V Lerma
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 4.  Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Authors:  Thomas Unger; Elena Kaschina
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Treatment of hypertension in black patients with angiotensin-converting enzyme inhibitors.

Authors:  N B Shulman
Journal:  J Natl Med Assoc       Date:  1988-03       Impact factor: 1.798

Review 6.  Using fixed-dose combination therapies to achieve blood pressure goals.

Authors:  Steven G Chrysant
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

7.  Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.

Authors:  R Fogari; A Zoppi; G D Malamani; G Marasi; A Vanasia; G Villa
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

8.  Efficacy and tolerability of delapril plus indapamide versus lisinopril plus hydrochlorothiazide combination treatments in mild to moderate hypertension: a multicenter, randomized clinical study.

Authors:  Giovanni Cremonesi; Luca Cavalieri; Stefano Bacchelli; Daniela Degli Esposti; Ivo Cikes; Jurij Dobovisek; Jan Zeman; Claudio Borghi; Ettore Ambrosioni
Journal:  Curr Ther Res Clin Exp       Date:  2003-05

9.  Combination therapy in hypertension.

Authors:  Alan H Gradman; Jan N Basile; Barry L Carter; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-10       Impact factor: 3.738

10.  Current perspectives on combination therapy in the management of hypertension.

Authors:  Samir G Mallat; Houssam S Itani; Bassem Y Tanios
Journal:  Integr Blood Press Control       Date:  2013-06-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.